AlloVir, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported net loss was USD 190.42 million compared to USD 168.71 million a year ago. Basic loss per share from continuing operations was USD 1.83 compared to USD 2.2 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.757 USD | +1.41% | -1.55% | +11.36% |
May. 13 | AlloVir, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Mar. 20 | North American Morning Briefing : Markets on Hold -2- | DJ |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.36% | 85.87M | |
+12.30% | 118B | |
+12.15% | 106B | |
-8.14% | 23.4B | |
-1.63% | 22.1B | |
-9.05% | 18.34B | |
-41.70% | 16.59B | |
-15.33% | 15.97B | |
+5.80% | 14.03B | |
+28.03% | 11.67B |
- Stock Market
- Equities
- ALVR Stock
- News AlloVir, Inc.
- AlloVir, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023